226 related articles for article (PubMed ID: 29952306)
21. Model for assessing the efficiency of biologic drugs in the treatment of moderate to severe psoriasis for one year in clinical practice in Spain.
Puig L; López-Ferrer A; Vilarrasa E; García I; Fernández-del Olmo R
Actas Dermosifiliogr; 2016; 107(1):34-43. PubMed ID: 26365029
[TBL] [Abstract][Full Text] [Related]
22. Biologic drug survival in Israeli psoriasis patients.
Shalom G; Cohen AD; Ziv M; Eran CB; Feldhamer I; Freud T; Berman E; Oren S; Hodak E; Pavlovsky L
J Am Acad Dermatol; 2017 Apr; 76(4):662-669.e1. PubMed ID: 28038888
[TBL] [Abstract][Full Text] [Related]
23. Use of biological drugs in patients with psoriasis and psoriatic arthritis in Italy: Results from the PSONG survey.
Potenza MC; Peris K; Berardesca E; Bianchi L; Richetta A; Bernardini N; De Simone C; Teoli M; Zangrilli A; D'epiro S; Orsini D; Narcisi A; Chimenti S; Costanzo A
Dermatol Ther; 2018 Jan; 31(1):. PubMed ID: 29215183
[TBL] [Abstract][Full Text] [Related]
24. Paradoxical onset of psoriatic arthritis during treatment with biologic agents for plaque psoriasis: a combined dermatology and rheumatology clinical study.
Napolitano M; Balato N; Caso F; Costa L; Megna M; Cirillo T; Balato A; Scarpa R
Clin Exp Rheumatol; 2017; 35(1):137-140. PubMed ID: 27749221
[TBL] [Abstract][Full Text] [Related]
25. ORBIT (Outcome and Retention Rate of Biologic Treatments for Psoriasis): A retrospective observational study on biologic drug survival in daily practice.
Vilarrasa E; Notario J; Bordas X; López-Ferrer A; Gich IJ; Puig L
J Am Acad Dermatol; 2016 Jun; 74(6):1066-72. PubMed ID: 27004803
[TBL] [Abstract][Full Text] [Related]
26. Drug survival of biologics in treating psoriasis: a meta-analysis of real-world evidence.
Lin PT; Wang SH; Chi CC
Sci Rep; 2018 Oct; 8(1):16068. PubMed ID: 30375427
[TBL] [Abstract][Full Text] [Related]
27. Differential Drug Survival of Second-Line Biologic Therapies in Patients with Psoriasis: Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR).
Iskandar IYK; Warren RB; Lunt M; Mason KJ; Evans I; McElhone K; Smith CH; Reynolds NJ; Ashcroft DM; Griffiths CEM;
J Invest Dermatol; 2018 Apr; 138(4):775-784. PubMed ID: 29080680
[TBL] [Abstract][Full Text] [Related]
28. Patient Preference for Dosing Frequency Based on Prior Biologic Experience.
Zhang M; Carter C; Olson WH; Johnson MP; Brennem SK; Lee S; Farahi K
J Drugs Dermatol; 2017 Mar; 16(3):220-226. PubMed ID: 28301617
[TBL] [Abstract][Full Text] [Related]
29. Serum interleukin-6 levels in response to biologic treatment in patients with psoriasis.
Muramatsu S; Kubo R; Nishida E; Morita A
Mod Rheumatol; 2017 Jan; 27(1):137-141. PubMed ID: 27194220
[TBL] [Abstract][Full Text] [Related]
30. A retrospective study on drug survival of biologic among patients with psoriasis seen in tertiary hospital in Johor Malaysia.
Mashor M; Wong KW; Tey KE; Choon SE
Med J Malaysia; 2022 Nov; 77(6):689-695. PubMed ID: 36448386
[TBL] [Abstract][Full Text] [Related]
31. Ustekinumab in patients previously treated with TNFα inhibitors: a real-life study.
Pinheiro RR; Duarte B; Ferreira A; Cabete J
Eur J Dermatol; 2018 Feb; 28(1):89-91. PubMed ID: 29400282
[No Abstract] [Full Text] [Related]
32. Psoriasis Area and Severity Index response in moderate-severe psoriatic patients switched to adalimumab: results from the OPPSA study.
Talamonti M; Galluzzo M; Bernardini N; Caldarola G; Persechino S; Cantoresi F; Egan CG; Potenza C; Peris K; Bianchi L
J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1737-1744. PubMed ID: 29776016
[TBL] [Abstract][Full Text] [Related]
33. Use of Biological Drugs for Psoriasis: A Drug-Utilization Study Using Tuscan Administrative Databanks.
Giometto S; Tillati S; Baglietto L; De Bortoli N; Mosca M; Conte M; Tuccori M; Gini R; Lucenteforte E
Int J Environ Res Public Health; 2022 Jun; 19(11):. PubMed ID: 35682382
[TBL] [Abstract][Full Text] [Related]
34. Biologics combined with conventional systemic agents or phototherapy for the treatment of psoriasis: real-life data from PSONET registries.
Busard CI; Cohen AD; Wolf P; Gkalpakiotis S; Cazzaniga S; Stern RS; Hutten BA; Feldhamer I; Quehenberger F; Lichem R; Kojanova M; Adenubiova E; Addis A; Naldi L; Spuls PI
J Eur Acad Dermatol Venereol; 2018 Feb; 32(2):245-253. PubMed ID: 28898541
[TBL] [Abstract][Full Text] [Related]
35. Scalp psoriasis and biologic agents: a retrospective, comparative study from a tertiary psoriasis referral centre.
Fotiadou C; Lazaridou E; Sotiriou E; Kyrgidis A; Apalla Z; Ioannides D
J Eur Acad Dermatol Venereol; 2016 Dec; 30(12):2091-2096. PubMed ID: 27406435
[TBL] [Abstract][Full Text] [Related]
36. Increase in antinuclear antibody levels through biologic treatment for psoriasis.
Miki M; Endo C; Naka Y; Fukuya Y; Kobayashi S; Kawashima M; Tsunemi Y
J Dermatol; 2019 Feb; 46(2):e50-e51. PubMed ID: 30051919
[No Abstract] [Full Text] [Related]
37. Current biological therapies for use in HIV-positive patients with psoriasis: case report of gesulkumab used and review.
Bartos G; Cline A; Beroukhim K; Burrall BA; Feldman SR
Dermatol Online J; 2018 Nov; 24(11):. PubMed ID: 30695971
[TBL] [Abstract][Full Text] [Related]
38. On clinical thresholds, clinical equivalents and indirect comparisons of biological treatments for moderate-to-severe psoriasis.
Puig L
J Clin Pharm Ther; 2015 Apr; 40(2):131-4. PubMed ID: 25627250
[TBL] [Abstract][Full Text] [Related]
39. Annual acquisition and administration cost of biologic response modifiers per patient with rheumatoid arthritis, psoriasis, psoriatic arthritis, or ankylosing spondylitis.
Bonafede M; Joseph GJ; Princic N; Harrison DJ
J Med Econ; 2013 Sep; 16(9):1120-8. PubMed ID: 23808901
[TBL] [Abstract][Full Text] [Related]
40. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics.
Menter A; Strober BE; Kaplan DH; Kivelevitch D; Prater EF; Stoff B; Armstrong AW; Connor C; Cordoro KM; Davis DMR; Elewski BE; Gelfand JM; Gordon KB; Gottlieb AB; Kavanaugh A; Kiselica M; Korman NJ; Kroshinsky D; Lebwohl M; Leonardi CL; Lichten J; Lim HW; Mehta NN; Paller AS; Parra SL; Pathy AL; Rupani RN; Siegel M; Wong EB; Wu JJ; Hariharan V; Elmets CA
J Am Acad Dermatol; 2019 Apr; 80(4):1029-1072. PubMed ID: 30772098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
